創薬アウトソーシングの世界市場2018-2022:小分子、生物製剤

【英語タイトル】Global Drug Discovery Outsourcing Market 2018-2022

Technavioが出版した調査資料(IRTNTR20430)・商品コード:IRTNTR20430
・発行会社(調査会社):Technavio
・発行日:2018年2月16日
・ページ数:123
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Technavio社が発行した当調査レポートでは、創薬アウトソーシングの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、創薬アウトソーシングの世界市場規模及び予測、製品別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。

・エグゼクティブサマリー
・創薬アウトソーシングの世界市場:市場概観
・創薬アウトソーシングの世界市場:業界の構造分析
・創薬アウトソーシングの世界市場:市場規模及び予測
・創薬アウトソーシングの世界市場:製品別分析
・創薬アウトソーシングの世界市場:地域別分析
・創薬アウトソーシングの世界市場:成長要因
・創薬アウトソーシングの世界市場:課題
・創薬アウトソーシングの世界市場:市場動向
・創薬アウトソーシングの世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

About Drug Discovery Outsourcing
Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs, and serve the local markets.

Technavio’s analysts forecast the global drug discovery outsourcing market to grow at a CAGR of 12.13% during the period 2018-2022.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global drug discovery outsourcing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Drug Discovery Outsourcing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Charles River
• Domainex
• EVOTEC
• GenScript
• GVK Biosciences

[Market driver]
• Prioritization of core competencies
• For a full, detailed list, view our report

[Market challenge]
• Limited manufacturing standardization
• For a full, detailed list, view our report

[Market trend]
• Increased demand for regenerative medicine
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Small molecules– Market size and forecast 2017-2022
• Biologics – Market size and forecast 2017-2022
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Increased demand for regenerative medicine
• Increased number of M&A
• Presence of value-added services

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Charles River
• Domainex
• EVOTEC
• GenScript
• GVK Biosciences
• Laboratory Corporation of America
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits] Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition – Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global drug discovery outsourcing market – Market size and forecast 2017-2022 ($ bn)
Exhibit 08: Global drug discovery outsourcing market – Year over year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2017-2022
Exhibit 17: Product – Market share 2017-2022 (%)
Exhibit 18: Comparison by product
Exhibit 19: Small molecules– Market size and forecast 2017-2022 ($ bn)
Exhibit 20: Characteristics of small molecules drugs compared with biologics
Exhibit 21: Small molecules– Year over year growth 2018-2022 (%)
Exhibit 22: Biologics– Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Biologics– Year over year growth 2018-2022 (%)
Exhibit 24: Popular biologics
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global – Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 30: Americas – Year over year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 33: EMEA – Year over year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 36: APAC – Year over year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: Competitive advantage among vendors
Exhibit 40: Examples of global pharmaceutical companies sourcing from contract manufacturers
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendors Covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Vendor overview
Exhibit 48: Charles River – Business segments
Exhibit 49: Charles River – Organizational developments
Exhibit 50: Charles River – Geographic focus
Exhibit 51: Charles River – Segment focus
Exhibit 52: Charles River – Key offerings
Exhibit 53: Vendor overview
Exhibit 54: Domainex – Business segments
Exhibit 55: Domainex – Organizational developments
Exhibit 56: Domainex – Geographic focus
Exhibit 57: Domainex – Segment focus
Exhibit 58: Domainex – Key offerings
Exhibit 59: Vendor overview
Exhibit 60: EVOTEC– Business segments
Exhibit 61: EVOTEC– Organizational developments
Exhibit 62: EVOTEC– Geographic focus
Exhibit 63: EVOTEC– Segment focus
Exhibit 64: EVOTEC– Key offerings
Exhibit 65: Vendor overview
Exhibit 66: GenScript– Business segments
Exhibit 67: GenScript– Organizational developments
Exhibit 68: GenScript– Geographic focus
Exhibit 69: GenScript– Segment focus
Exhibit 70: GenScript– Key offerings
Exhibit 71: Vendor overview
Exhibit 72: GVK Biosciences– Business segments
Exhibit 73: GVK Biosciences– Organizational developments
Exhibit 74: GVK Biosciences– Geographic focus
Exhibit 75: GVK Biosciences– Segment focus
Exhibit 76: GVK Biosciences– Key offerings
Exhibit 77: Vendor overview
Exhibit 78: Laboratory Corporation of America– Business segments
Exhibit 79: Laboratory Corporation of America– Organizational developments
Exhibit 80: Laboratory Corporation of America– Geographic focus
Exhibit 81: Laboratory Corporation of America– Segment focus
Exhibit 82: Laboratory Corporation of America– Key offerings



【掲載企業】

Charles River, Domainex, EVOTEC, GenScript, and GVK Biosciences.

★調査レポート[創薬アウトソーシングの世界市場2018-2022:小分子、生物製剤] (コード:IRTNTR20430)販売に関する免責事項を必ずご確認ください。
★調査レポート[創薬アウトソーシングの世界市場2018-2022:小分子、生物製剤]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆